Vicarious Surgical Inc. RBOT
0.10
0.05
100.00%
as of 25 Sep
- Market cap
- $14.3M
- P/E
- 0.0×
Follow RBOT
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
Current Ratio |
— | — | 21.04 | 28.56 | 14.35 | 13.87 | 6.74 | 2.97 |
Net Debt/EBITDA |
— | — | 1.31 | 4.55 | 1.27 | 1.25 | 0.76 | 0.20 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.70% | 11.18% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | — | 0.00 | 0.02 | 0.14 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | — | 0.94 | 0.95 | (11.87) | 0.88 | 0.79 | 0.90 |
Capex/Depreciation |
— | — | (0.76) | (3.82) | (4.51) | (0.90) | (0.09) | (0.09) |
Interest Coverage |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | — | (29.23%) | (70.45%) | 5.31% | (68.01%) | (87.40%) | (177.51%) | |
| — | 0.00% | (144.76%) | (35.30%) | 3.20% | (54.64%) | (67.41%) | (114.96%) | |
ROIC |
— | — | 0.00% | 0.00% | (475.61%) | 0.00% | 0.00% | (63,809.95%) |
Return on Tangible Assets |
— | — | (76.84%) | (20.19%) | 4.35% | (71.02%) | (130.34%) | (560.82%) |
Research and Development Expense of Revenue |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
— | — | (4.64) | (10.74) | (16.41) | (13.14) | (8.52) | (7.37) |
Cash per Share |
— | — | 6.43 | 53.89 | 28.65 | 20.17 | 8.34 | 1.60 |
Shareholders Equity per Share |
— | — | 6.43 | 25.81 | 27.38 | 20.13 | 7.93 | 1.61 |
Interest Debt per Share |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | — | 6.43 | 25.81 | 27.38 | 20.13 | 7.93 | 1.61 |
Free Cash Flow |
— | — | (12.16) | (34.59) | (66.56) | (63.97) | (50.14) | (45.21) |
Working Capital |
— | — | 16.31 | 172.13 | 112.01 | 93.67 | 44.03 | 7.68 |
Capital Expenditures |
— | — | (0.12) | (1.29) | (5.35) | (1.67) | (0.18) | (0.13) |
Net Current Asset Value |
— | — | 16.19 | 79.79 | 91.16 | 79.06 | 30.68 | 1.84 |
| Other line items | ||||||||
Quick Ratio |
— | — | 20.72 | 27.78 | 13.85 | 13.49 | 6.40 | 2.51 |
Depreciation/Fixed assets |
— | — | 0.35 | 0.15 | 0.18 | 0.29 | 0.47 | 1.12 |
Cash ROIC |
— | — | (37.02%) | (13.79%) | (27.91%) | (35.03%) | (56.82%) | (236.05%) |
Accounts Payable Turnover |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | — |
Revenue per Share |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
— | — | (4.59) | (10.34) | (15.09) | (12.80) | (8.49) | (7.35) |
Capex per Share |
— | — | (0.05) | (0.40) | (1.32) | (0.34) | (0.03) | (0.02) |
Average Payables |
— | — | 0.76 | 0.94 | 1.62 | 1.49 | 1.21 | 1.03 |
Average Assets |
— | 0.00 | 8.89 | 99.73 | 160.99 | 130.08 | 93.79 | 43.65 |
Average Common Equity |
— | — | 44.05 | 49.97 | 97.07 | 104.51 | 72.33 | 28.27 |
Capex to Sales |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates